212 related articles for article (PubMed ID: 24625977)
1. Ubiquitin-like (UBX)-domain-containing protein, UBXN2A, promotes cell death by interfering with the p53-Mortalin interactions in colon cancer cells.
Sane S; Abdullah A; Boudreau DA; Autenried RK; Gupta BK; Wang X; Wang H; Schlenker EH; Zhang D; Telleria C; Huang L; Chauhan SC; Rezvani K
Cell Death Dis; 2014 Mar; 5(3):e1118. PubMed ID: 24625977
[TBL] [Abstract][Full Text] [Related]
2. A plant alkaloid, veratridine, potentiates cancer chemosensitivity by UBXN2A-dependent inhibition of an oncoprotein, mortalin-2.
Abdullah A; Sane S; Branick KA; Freeling JL; Wang H; Zhang D; Rezvani K
Oncotarget; 2015 Sep; 6(27):23561-81. PubMed ID: 26188124
[TBL] [Abstract][Full Text] [Related]
3. UBXN2A enhances CHIP-mediated proteasomal degradation of oncoprotein mortalin-2 in cancer cells.
Sane S; Hafner A; Srinivasan R; Masood D; Slunecka JL; Noldner CJ; Hanson AD; Kruisselbrink T; Wang X; Wang Y; Yin J; Rezvani K
Mol Oncol; 2018 Oct; 12(10):1753-1777. PubMed ID: 30107089
[TBL] [Abstract][Full Text] [Related]
4. Structural studies of UBXN2A and mortalin interaction and the putative role of silenced UBXN2A in preventing response to chemotherapy.
Sane S; Abdullah A; Nelson ME; Wang H; Chauhan SC; Newton SS; Rezvani K
Cell Stress Chaperones; 2016 Mar; 21(2):313-26. PubMed ID: 26634371
[TBL] [Abstract][Full Text] [Related]
5. Nucleocytoplasmic Translocation of UBXN2A Is Required for Apoptosis during DNA Damage Stresses in Colon Cancer Cells.
Abdullah A; Sane S; Freeling JL; Wang H; Zhang D; Rezvani K
J Cancer; 2015; 6(11):1066-78. PubMed ID: 26516353
[TBL] [Abstract][Full Text] [Related]
6. Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 protein.
Wadhwa R; Yaguchi T; Hasan MK; Mitsui Y; Reddel RR; Kaul SC
Exp Cell Res; 2002 Apr; 274(2):246-53. PubMed ID: 11900485
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppression by apoptotic and anti-angiogenic effects of mortalin-targeting adeno-oncolytic virus.
Yoo JY; Ryu J; Gao R; Yaguchi T; Kaul SC; Wadhwa R; Yun CO
J Gene Med; 2010 Jul; 12(7):586-95. PubMed ID: 20603860
[TBL] [Abstract][Full Text] [Related]
8. Restoration of p53 functions by suppression of mortalin-p53 sequestration: an emerging target in cancer therapy.
Shankaranarayana AH; Meduri B; Pujar GV; Hariharapura RC; Sethu AK; Singh M; Bidye D
Future Med Chem; 2023 Nov; 15(22):2087-2112. PubMed ID: 37877348
[TBL] [Abstract][Full Text] [Related]
9. Identification and functional characterization of nuclear mortalin in human carcinogenesis.
Ryu J; Kaul Z; Yoon AR; Liu Y; Yaguchi T; Na Y; Ahn HM; Gao R; Choi IK; Yun CO; Kaul SC; Wadhwa R
J Biol Chem; 2014 Sep; 289(36):24832-44. PubMed ID: 25012652
[TBL] [Abstract][Full Text] [Related]
10. Cytoplasmic sequestration of the tumor suppressor p53 by a heat shock protein 70 family member, mortalin, in human colorectal adenocarcinoma cell lines.
Gestl EE; Anne Böttger S
Biochem Biophys Res Commun; 2012 Jun; 423(2):411-6. PubMed ID: 22683628
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of tumor suppressor p53 by mot-2, a hsp70 family member.
Wadhwa R; Takano S; Robert M; Yoshida A; Nomura H; Reddel RR; Mitsui Y; Kaul SC
J Biol Chem; 1998 Nov; 273(45):29586-91. PubMed ID: 9792667
[TBL] [Abstract][Full Text] [Related]
12. An N-terminal region of mot-2 binds to p53 in vitro.
Kaul SC; Reddel RR; Mitsui Y; Wadhwa R
Neoplasia; 2001; 3(2):110-4. PubMed ID: 11420746
[TBL] [Abstract][Full Text] [Related]
13. Activation of wild type p53 function by its mortalin-binding, cytoplasmically localizing carboxyl terminus peptides.
Kaul SC; Aida S; Yaguchi T; Kaur K; Wadhwa R
J Biol Chem; 2005 Nov; 280(47):39373-9. PubMed ID: 16176931
[TBL] [Abstract][Full Text] [Related]
14. Acriflavine enhances radiosensitivity of colon cancer cells through endoplasmic reticulum stress-mediated apoptosis.
Lim MJ; Ahn JY; Han Y; Yu CH; Kim MH; Lee SL; Lim DS; Song JY
Int J Biochem Cell Biol; 2012 Aug; 44(8):1214-22. PubMed ID: 22564437
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional inactivation of p53 by deletions and single amino acid changes in mouse mot-1 protein.
Kaul SC; Takano S; Reddel RR; Mitsui Y; Wadhwa R
Biochem Biophys Res Commun; 2000 Dec; 279(2):602-6. PubMed ID: 11118332
[TBL] [Abstract][Full Text] [Related]
16. NIH 3T3 cells malignantly transformed by mot-2 show inactivation and cytoplasmic sequestration of the p53 protein.
Wadhwa R; Takano S; Mitsui Y; Kaul SC
Cell Res; 1999 Dec; 9(4):261-9. PubMed ID: 10628835
[TBL] [Abstract][Full Text] [Related]
17. Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin.
Lim DY; Park JH
Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1060-8. PubMed ID: 19264955
[TBL] [Abstract][Full Text] [Related]
18. Functional significance of point mutations in stress chaperone mortalin and their relevance to Parkinson disease.
Wadhwa R; Ryu J; Ahn HM; Saxena N; Chaudhary A; Yun CO; Kaul SC
J Biol Chem; 2015 Mar; 290(13):8447-56. PubMed ID: 25645922
[TBL] [Abstract][Full Text] [Related]
19. Linear ubiquitin chain induces apoptosis and inhibits tumor growth.
Qin Z; Jiang W; Wang G; Sun Y; Xiao W
Apoptosis; 2018 Jan; 23(1):16-26. PubMed ID: 29185083
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of Mdm2 triggers growth arrest and promotes DNA breakage in mouse colon tumors and human colon cancer cells.
Rigatti MJ; Verma R; Belinsky GS; Rosenberg DW; Giardina C
Mol Carcinog; 2012 May; 51(5):363-78. PubMed ID: 21557332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
